Olivier Delattre

54.0k total citations · 6 hit papers
414 papers, 26.1k citations indexed

About

Olivier Delattre is a scholar working on Molecular Biology, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Olivier Delattre has authored 414 papers receiving a total of 26.1k indexed citations (citations by other indexed papers that have themselves been cited), including 191 papers in Molecular Biology, 113 papers in Neurology and 113 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Olivier Delattre's work include Sarcoma Diagnosis and Treatment (103 papers), Neuroblastoma Research and Treatments (90 papers) and Chromatin Remodeling and Cancer (54 papers). Olivier Delattre is often cited by papers focused on Sarcoma Diagnosis and Treatment (103 papers), Neuroblastoma Research and Treatments (90 papers) and Chromatin Remodeling and Cancer (54 papers). Olivier Delattre collaborates with scholars based in France, United States and Germany. Olivier Delattre's co-authors include Gilles Thomas, Alain Aurias, Jessica Zucman‐Rossi, Isabelle Janoueix‐Lerosey, Thomas Melot, Martine Peter, Gaëlle Pierron, Gudrun Schleiermacher, Nicolas Sévenet and Franck Tirode and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Olivier Delattre

407 papers receiving 25.7k citations

Hit Papers

Gene fusion with an ETS DNA-binding domain caused by chro... 1992 2026 2003 2014 1992 1998 1994 2011 2008 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
    1992 1.4k citations Olivier Delattre, Heinrich Kovar et al. profile →
  2. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer
    1998 1.1k citations Isabella Versteege, Olivier Delattre et al. profile →
  3. The Ewing Family of Tumors -- A Subgroup of Small-Round-Cell Tumors Defined by Specific Chimeric Transcripts
    1994 816 citations Olivier Delattre, Xavier Sastre‐Garau et al. profile →
  4. Control-FREEC: a tool for assessing copy number and allelic content using next-generation sequencing data
    2011 623 citations Valentina Boeva, Tatiana Popova et al. Bioinformatics profile →
  5. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
    2008 622 citations Isabelle Janoueix‐Lerosey, Valérie Combaret et al. profile →
  6. Ewing sarcoma
    2018 482 citations Didier Surdez, Heinrich Kovar et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olivier Delattre France 82 13.8k 9.2k 6.2k 5.5k 5.3k 414 26.1k
Fredrik Mertens Sweden 75 7.1k 0.5× 12.2k 1.3× 6.0k 1.0× 3.6k 0.7× 1.7k 0.3× 397 24.1k
Timothy J. Triche United States 70 7.4k 0.5× 7.8k 0.9× 3.7k 0.6× 2.8k 0.5× 2.5k 0.5× 268 17.0k
Claudio Doglioni Italy 83 8.6k 0.6× 5.7k 0.6× 11.6k 1.9× 3.2k 0.6× 1.9k 0.4× 475 26.8k
Masashi Fukayama Japan 78 8.4k 0.6× 6.1k 0.7× 8.3k 1.3× 3.5k 0.6× 1.3k 0.3× 615 24.1k
Christopher L. Corless United States 86 6.3k 0.5× 17.0k 1.9× 5.9k 0.9× 3.1k 0.6× 3.7k 0.7× 321 31.0k
Gilles Thomas France 62 6.5k 0.5× 4.5k 0.5× 4.1k 0.7× 2.7k 0.5× 2.0k 0.4× 248 16.1k
Nils Mandahl Sweden 74 5.7k 0.4× 8.9k 1.0× 4.1k 0.7× 3.3k 0.6× 1.2k 0.2× 389 18.1k
Alexander J. Lazar United States 77 6.5k 0.5× 9.2k 1.0× 8.9k 1.4× 2.9k 0.5× 1.9k 0.4× 448 21.1k
Anke van den Berg Netherlands 60 8.0k 0.6× 4.8k 0.5× 5.6k 0.9× 5.3k 1.0× 1.2k 0.2× 364 19.3k
Scott J. Rodig United States 85 10.5k 0.8× 6.9k 0.7× 18.7k 3.0× 4.4k 0.8× 1.9k 0.4× 347 33.8k

Countries citing papers authored by Olivier Delattre

Since Specialization
Citations

This map shows the geographic impact of Olivier Delattre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Delattre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Delattre more than expected).

Fields of papers citing papers by Olivier Delattre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivier Delattre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Delattre. The network helps show where Olivier Delattre may publish in the future.

Co-authorship network of co-authors of Olivier Delattre

This figure shows the co-authorship network connecting the top 25 collaborators of Olivier Delattre. A scholar is included among the top collaborators of Olivier Delattre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivier Delattre. Olivier Delattre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deveau, Paul, Léo Colmet‐Daage, Derek A. Oldridge, et al.. (2018). QuantumClone: clonal assessment of functional mutations in cancer based on a genotype-aware method for clonal reconstruction. Bioinformatics. 34(11). 1808–1816. 18 indexed citations
2.
Chicard, Mathieu, Léo Colmet‐Daage, Nathalie Clément, et al.. (2017). Whole-Exome Sequencing of Cell-Free DNA Reveals Temporo-spatial Heterogeneity and Identifies Treatment-Resistant Clones in Neuroblastoma. Clinical Cancer Research. 24(4). 939–949. 98 indexed citations
3.
Gruel, Nadège, Vanessa Benhamo, Jaydutt Bhalshankar, et al.. (2014). Polarity gene alterations in pure invasive micropapillary carcinomas of the breast. Breast Cancer Research. 16(3). R46–R46. 34 indexed citations
4.
Popova, Tatiana, Élodie Manié, Guillaume Rieunier, et al.. (2012). Ploidy and Large-Scale Genomic Instability Consistently Identify Basal-like Breast Carcinomas with BRCA1/2 Inactivation. Cancer Research. 72(21). 5454–5462. 418 indexed citations
5.
Cazes, Alex, Caroline Louis‐Brennetot, Pierre Mazot, et al.. (2012). Characterization of Rearrangements Involving the ALK Gene Reveals a Novel Truncated Form Associated with Tumor Aggressiveness in Neuroblastoma. Cancer Research. 73(1). 195–204. 44 indexed citations
6.
Missiaglia, Edoardo, Dan Williamson, Julia Chisholm, et al.. (2012). PAX3/FOXO1 Fusion Gene Status Is the Key Prognostic Molecular Marker in Rhabdomyosarcoma and Significantly Improves Current Risk Stratification. Journal of Clinical Oncology. 30(14). 1670–1677. 230 indexed citations
7.
Surdez, Didier, Magdalena Benetkiewicz, Virginie Perrin, et al.. (2012). Targeting the EWSR1-FLI1 Oncogene-Induced Protein Kinase PKC-β Abolishes Ewing Sarcoma Growth. Cancer Research. 72(17). 4494–4503. 44 indexed citations
8.
Reyal, Fabien, Charlotte Guyader, Charles Decraene, et al.. (2012). Molecular profiling of patient-derived breast cancer xenografts. Breast Cancer Research. 14(1). R11–R11. 140 indexed citations
9.
Reiff, Tobias, Leslie Huber, Marco Krämer, et al.. (2011). Midkine and Alk signaling in sympathetic neuron proliferation and neuroblastoma predisposition. Development. 138(21). 4699–4708. 66 indexed citations
10.
Stücklin, Ana Guerreiro, Sarah Fattet, Alexandra N. Elsing, et al.. (2011). A Sensitized RNA Interference Screen Identifies a Novel Role for the PI3K p110γ Isoform in Medulloblastoma Cell Proliferation and Chemoresistance. Molecular Cancer Research. 9(7). 925–935. 42 indexed citations
11.
Gravier, Eléonore, Gaëlle Pierron, Anne Vincent‐Salomon, et al.. (2010). A prognostic DNA signature for T1T2 node‐negative breast cancer patients. Genes Chromosomes and Cancer. 49(12). 1125–1134. 60 indexed citations
12.
Odri, Guillaume, Gaëlle Picarda, Séverine Battaglia, et al.. (2010). Zoledronic Acid as a New Adjuvant Therapeutic Strategy for Ewing's Sarcoma Patients. Cancer Research. 70(19). 7610–7619. 56 indexed citations
13.
Preter, Katleen De, Joëlle Vermeulen, Benedikt Brors, et al.. (2010). Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene Signature. Clinical Cancer Research. 16(5). 1532–1541. 65 indexed citations
14.
Deley, Marie‐Cécile Le, Olivier Delattre, Karl‐Ludwig Schaefer, et al.. (2010). Impact of EWS-ETS Fusion Type on Disease Progression in Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor: Prospective Results From the Cooperative Euro-E.W.I.N.G. 99 Trial. Journal of Clinical Oncology. 28(12). 1982–1988. 125 indexed citations
15.
Williamson, Daniel, Edoardo Missiaglia, Aurélien de Reyniès, et al.. (2010). Fusion Gene–Negative Alveolar Rhabdomyosarcoma Is Clinically and Molecularly Indistinguishable From Embryonal Rhabdomyosarcoma. Journal of Clinical Oncology. 28(13). 2151–2158. 326 indexed citations
16.
Caramel, Julie, Frédérique Quignon, & Olivier Delattre. (2008). RhoA-Dependent Regulation of Cell Migration by the Tumor Suppressor hSNF5/INI1. Cancer Research. 68(15). 6154–6161. 42 indexed citations
17.
Bernard‐Pierrot, Isabelle, Nadège Gruel, Nicolas Stransky, et al.. (2008). Characterization of the Recurrent 8p11-12 Amplicon Identifies PPAPDC1B, a Phosphatase Protein, as a New Therapeutic Target in Breast Cancer. Cancer Research. 68(17). 7165–7175. 73 indexed citations
18.
Vincent‐Salomon, Anne, Carlo Lucchesi, Nadège Gruel, et al.. (2008). Integrated Genomic and Transcriptomic Analysis of Ductal Carcinoma In situ of the Breast. Clinical Cancer Research. 14(7). 1956–1965. 114 indexed citations
19.
Castex, Marie‐Pierre, Hervé Rubie, Michaël C.G. Stevens, et al.. (2007). Extraosseous Localized Ewing Tumors: Improved Outcome With Anthracyclines—The French Society of Pediatric Oncology and International Society of Pediatric Oncology. Journal of Clinical Oncology. 25(10). 1176–1182. 52 indexed citations
20.
Medjkane, Souhila, Eugene Novikov, Isabella Versteege, & Olivier Delattre. (2004). The Tumor Suppressor hSNF5/INI1 Modulates Cell Growth and Actin Cytoskeleton Organization. Cancer Research. 64(10). 3406–3413. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fredrik Mertens Breakdown of academic impact, for papers by Timothy J. Triche Breakdown of academic impact, for papers by Claudio Doglioni Breakdown of academic impact, for papers by Masashi Fukayama Breakdown of academic impact, for papers by Christopher L. Corless Breakdown of academic impact, for papers by Gilles Thomas Breakdown of academic impact, for papers by Nils Mandahl Breakdown of academic impact, for papers by Alexander J. Lazar Breakdown of academic impact, for papers by Anke van den Berg Breakdown of academic impact, for papers by Scott J. Rodig
Rankless by CCL
2026